Novartis, Bayer and patent drafting: what’s on this week

Tuesday August 21, 2012

The IP Office of the Philippines will be holding a course, Patent Drafting II, for examination passers only, location TBC

Hearing before India’s Intellectual Property Appellate Board in Natco v Bayer, concerning the compulsory license granted to Natco to manufacture generic versions of Bayer’s sorafenib.

Wednesday August 22

India’s Supreme Court is due to hear final arguments between Switzerland’s Novartis against India's patent office over its refusal to grant a patent over cancer drug Glivec.

The USPTO is seeking volunteers to test the new electronic filing system for administrative trials linked to post grant review, inter partes review and the transitional programme for covered business methods.

Friday August 24, 2012

The IP Office of the Philippines will be hosting a meeting with the Japan-Asia Young Scientist & Engineer Study (JAYSES) at its offices in Taguig City.

Last day of Apple v Samsung trial in California.